Displaying 1-10 of 10 result(s).
| Board Name | Posts By Gabriel_S | Post Created |
|---|---|---|
| PCTL PCT Ltd. | Well...just sent them an email. Hop | 04/06/2020 12:19:43 PM |
| PCTL PCT Ltd. | MMs indicating to prepare for an in | 04/06/2020 12:02:50 PM |
| PCTL PCT Ltd. | One of the MMs just signaled ...... | 04/06/2020 11:50:22 AM |
| PCTL PCT Ltd. | MMs trying to keep this trading sid | 04/06/2020 10:58:45 AM |
| PCTL PCT Ltd. | So how do I get more than 5 posts a | 04/05/2020 9:02:12 PM |
| PCTL PCT Ltd. | Pullbacks are needed to get thru re  (1) | 04/05/2020 3:17:12 PM |
| TMRC Texas Mineral Resources Corp | We All Need to Calm Down About Rare (1) | 06/19/2019 4:50:13 PM |
| TMRC Texas Mineral Resources Corp | Whatever, you've posted the exact s | 06/19/2019 4:30:23 PM |
| KALY Kali, Inc. | KALY now current on Annual report a | 05/17/2019 10:20:22 PM |
| KALY Kali, Inc. | Kali Inc Lawyers respnse to the Cav | 04/13/2019 5:09:24 PM |
Recent Articles
- Assembly Health Welcomes New Executives to Boost Growth
- Xtant Medical Reports Strong Revenue Growth and Strategic Moves
- March Earnings Report Reveals Growth for Small Businesses
- International Governance Report Set to Transform Political Insight
- Markets4you Named Most Innovative Trading App and Cost Cuts
- Reju Collaborates with Rematrix to Transform Textile Waste
- Jacobs Receives Major Environmental Services Contract with USAF
- Revolutionizing Legal Practice with Anytime AI's Latest Platform
- United Solar Holding Welcomes Binyam Giorgis as CFO
- Iveco Group Shareholders Approve Key Resolutions at AGM
- American Tungsten Celebrates Executive Order Supporting Critical Minerals
- Garrett Motion Announces Conference Call for Q1 2025 Results
- Avicanna's Management Cease Trade Order Successfully Revoked
- LAVA Therapeutics Secures Strategic Waiver Boosting Financial Health
- NextGen Digital Focuses on Long-Term Growth with Innovative Strategies
- Geomega Announces Progress on Innovative Bauxite Valorization
- South Bow Corp Safely Resumes Operations on Keystone Pipeline
- Key Highlights from Coop Pank AS's Annual Shareholder Meeting
- Celebrating Innovation: Global Health Leaders Honored
- Autoliv's Innovative Bernoulli Airbag Module Earns Recognition
- Abbott's Positive First Quarter Results and Future Outlook
- PleoPharma, Inc. Secures Key Patent for Cannabis Treatment
- Empowering Shareholders: The Future of TransCode Therapeutics
- Colombia's Successful Tender Offer for Global Bonds Due 2026
- Silvercorp Expands Production Goals and Cost Management Strategy
- Celebrating Global Health Innovators at Abu Dhabi Event 2025
- Empowering Future Babysitters with Red Cross Training Course
- MEXC Exchange Welcomes PAWS with a Strategic Listing
- BriaCell's Innovative Therapy Shows Promise for Breast Cancer Care
- UAB Energy Investments Reveals Financial Statements for 2024
- Paladin Energy Initiates Defense Against Class Action Lawsuit
- Mill Creek Residential Breaks Ground on Modera Weston Homes
- Exploring Leadership Challenges and Solutions for Local Governments
- Innovative Biotech Firm 28 Capital Begins New Journey
- Autoliv Innovates with Recognition for Safety Enhancements
- Draganfly Appoints Paul Goldenberg to Enhance Public Safety Strategies
- Innovative Research Highlights NT219's Effectiveness Against Cancer
- ISC Champions Shareholder Interests Against Plantro's Tender
- Rivalry Corp. Reports Notable Q1 2025 Performance Growth
- Spectral Medical Celebrates Tigris Trial's Enrollment Success
- Tonix Pharmaceuticals Highlights Innovations in Vaccine Development
- Cannara Biotech Announces Q2 2025 Financial Results Date
- INmune Bio Advances with CORDStrom™ Patent Milestone
- Madrigal Pharmaceuticals Leadership Transition and Future Goals
- U.S. Energy Corp. Strengthens Position with Strategic Acquisition
- Tilray Brands Proudly Ranks Among America's Top Craft Brewers
- Aya Gold & Silver Completes Strategic Deal with Mx2 Mining
- EyePoint Pharmaceuticals Enhances Talent with Stock Options Grant
- Sprott Physical Copper Trust Shifts to Prominent OTCQX Market
- Cullinan Therapeutics Initiates Phase 1 Trial for CLN-978